眼病-话题@MedSci

#眼病#

63篇内容 | 2634人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2204236, encodeId=82a1220423639, content=<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a> <a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a> <a href='/topic/show?id=506f4186905' target=_blank style='color:#2F92EE;'>#基因编辑疗法#</a>, objectTitle=‘四大顶刊’一周研究导读：基因编辑疗法治疗眼病，再获突破性进展；乳腺癌可少切除，还可降低水肿风险；尿液检测可准确诊断高级别前列腺癌，可减少约一半的不必要活检, objectType=article, longId=825534, objectId=d01182553409, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240511/1715435601098_5579292.jpg, objectUrl=/article/show_article.do?id=d01182553409, replyNumber=0, likeNumber=94, createdTime=2024-05-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d01182553409, moduleTitle=‘四大顶刊’一周研究导读：基因编辑疗法治疗眼病，再获突破性进展；乳腺癌可少切除，还可降低水肿风险；尿液检测可准确诊断高级别前列腺癌，可减少约一半的不必要活检, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d01182553409)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2177479, encodeId=3cbb21e747918, content=<a href='/topic/show?id=533248e474a' target=_blank style='color:#2F92EE;'>#干眼#</a> <a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=眼干、迎风流泪……你的眼睛可能生病了！JAMA子刊：这些方法或有效, objectType=article, longId=806738, objectId=e7f7806e3868, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=e7f7806e3868, replyNumber=0, likeNumber=75, createdTime=2023-12-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e7f7806e3868, moduleTitle=眼干、迎风流泪……你的眼睛可能生病了！JAMA子刊：这些方法或有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7f7806e3868)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1540540, encodeId=f0001540540b6, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读, objectType=article, longId=735191, objectId=e73fe3519133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e73fe3519133, replyNumber=0, likeNumber=44, createdTime=2022-08-09, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e73fe3519133, moduleTitle=甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e73fe3519133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540539, encodeId=7d461540539e2, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=BMC Ophthalmol ：泪腺脱出程度与甲状腺相关眼病临床特征相关性的回顾性观察, objectType=article, longId=299559, objectId=7c7629955999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c7629955999, replyNumber=0, likeNumber=79, createdTime=2022-02-25, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c7629955999, moduleTitle=BMC Ophthalmol ：泪腺脱出程度与甲状腺相关眼病临床特征相关性的回顾性观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c7629955999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540538, encodeId=279815405389f, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=ProQR的RNA疗法在关键的遗传性眼病研究中失败, objectType=article, longId=295606, objectId=befe29560674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=befe29560674, replyNumber=0, likeNumber=81, createdTime=2022-02-16, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=befe29560674, moduleTitle=ProQR的RNA疗法在关键的遗传性眼病研究中失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=befe29560674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540536, encodeId=214415405361b, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=Thyroid:短期口服或静脉使用激素预防放射性碘消融术Graves病患者眼病的进展, objectType=article, longId=217528, objectId=878d21e52831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=878d21e52831, replyNumber=0, likeNumber=88, createdTime=2021-09-25, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=878d21e52831, moduleTitle=Thyroid:短期口服或静脉使用激素预防放射性碘消融术Graves病患者眼病的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=878d21e52831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540537, encodeId=f5de154053ed7, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=Thyroid:Graves眼病患者使用前列腺素F2-α滴眼液（比马前列素）, objectType=article, longId=217495, objectId=8b2921e49547, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b2921e49547, replyNumber=0, likeNumber=73, createdTime=2021-09-24, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b2921e49547, moduleTitle=Thyroid:Graves眼病患者使用前列腺素F2-α滴眼液（比马前列素）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b2921e49547)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540535, encodeId=8a3c15405351f, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=JCEM：1型糖尿病患者腰围身高比和严重糖尿病眼病风险之间的关系, objectType=article, longId=217017, objectId=562121e0178c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=562121e0178c, replyNumber=0, likeNumber=65, createdTime=2021-09-14, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=562121e0178c, moduleTitle=JCEM：1型糖尿病患者腰围身高比和严重糖尿病眼病风险之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=562121e0178c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540534, encodeId=7fa91540534ac, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=JCEM：利妥昔单抗在治疗Graves眼病患者中没有获益？, objectType=article, longId=216732, objectId=b3fe216e3245, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3fe216e3245, replyNumber=0, likeNumber=74, createdTime=2021-09-07, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3fe216e3245, moduleTitle=JCEM：利妥昔单抗在治疗Graves眼病患者中没有获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3fe216e3245)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540533, encodeId=173e1540533a6, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=JCEM：利妥昔单抗靶向治疗在活动性中度至重度Graves眼病患者的疗效, objectType=article, longId=216674, objectId=c00c2166e4fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c00c2166e4fb, replyNumber=0, likeNumber=97, createdTime=2021-09-05, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c00c2166e4fb, moduleTitle=JCEM：利妥昔单抗靶向治疗在活动性中度至重度Graves眼病患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c00c2166e4fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540532, encodeId=adb81540532bc, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=FDA干眼病治疗药物开发指南（草案） 2020, objectType=article, longId=208536, objectId=53572085368d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53572085368d, replyNumber=0, likeNumber=82, createdTime=2021-03-18, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53572085368d, moduleTitle=FDA干眼病治疗药物开发指南（草案） 2020, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53572085368d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540531, encodeId=9beb1540531b8, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=沉默的致盲性眼病—青光眼，离我们不远, objectType=article, longId=207954, objectId=738620e95492, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=738620e95492, replyNumber=0, likeNumber=131, createdTime=2021-03-08, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=738620e95492, moduleTitle=沉默的致盲性眼病—青光眼，离我们不远, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=738620e95492)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540530, encodeId=dad3154053063, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=Nat Biomed Eng ：单碱基编辑首次在治疗遗传性眼病上取得成功，安全高效治疗先天性黑蒙症, objectType=article, longId=202401, objectId=36ec202401e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36ec202401e0, replyNumber=0, likeNumber=79, createdTime=2020-10-24, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36ec202401e0, moduleTitle=Nat Biomed Eng ：单碱基编辑首次在治疗遗传性眼病上取得成功，安全高效治疗先天性黑蒙症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36ec202401e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540529, encodeId=b8cd1540529a5, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=揉眼睛揉出了血斑？这些眼病看着吓人，多数不用治, objectType=article, longId=201190, objectId=02be201190f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02be201190f7, replyNumber=0, likeNumber=67, createdTime=2020-09-26, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02be201190f7, moduleTitle=揉眼睛揉出了血斑？这些眼病看着吓人，多数不用治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02be201190f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540528, encodeId=23f8154052824, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=女，12岁，色素性青光眼病例, objectType=article, longId=196728, objectId=6ba5196e28a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ba5196e28a9, replyNumber=0, likeNumber=72, createdTime=2020-07-01, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ba5196e28a9, moduleTitle=女，12岁，色素性青光眼病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ba5196e28a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540527, encodeId=6d7a154052ec9, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=HBM9161针对Graves眼病的临床试验获NMPA批件, objectType=article, longId=195214, objectId=8696195214be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8696195214be, replyNumber=0, likeNumber=74, createdTime=2020-06-04, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8696195214be, moduleTitle=HBM9161针对Graves眼病的临床试验获NMPA批件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8696195214be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540526, encodeId=0259154052683, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=STEM CELL REP：烟酰胺可缓解纤维化眼病及视力丧失, objectType=article, longId=191660, objectId=52ef191660c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52ef191660c4, replyNumber=0, likeNumber=0, createdTime=2020-04-09, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52ef191660c4, moduleTitle=STEM CELL REP：烟酰胺可缓解纤维化眼病及视力丧失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52ef191660c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540525, encodeId=c404154052591, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=2019美国甲状腺学会ATA：临床试验证实Teprotumumab可显着改善甲状腺眼病的眼胀、复视和炎症, objectType=article, longId=182365, objectId=732918236572, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=732918236572, replyNumber=0, likeNumber=84, createdTime=2019-11-06, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=732918236572, moduleTitle=2019美国甲状腺学会ATA：临床试验证实Teprotumumab可显着改善甲状腺眼病的眼胀、复视和炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=732918236572)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540524, encodeId=2aca1540524c6, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=“Graves眼病” 越治越重！主治医生该何去何从？, objectType=article, longId=180825, objectId=b4901808257f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4901808257f, replyNumber=0, likeNumber=97, createdTime=2019-10-11, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4901808257f, moduleTitle=“Graves眼病” 越治越重！主治医生该何去何从？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4901808257f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1540523, encodeId=16b315405234e, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, objectTitle=感染性眼病细菌学检查操作专家共识（2019）, objectType=article, longId=166370, objectId=c5591663e0d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5591663e0d0, replyNumber=0, likeNumber=60, createdTime=2019-05-20, rootId=0, userName=pps20023, userId=b85c13256921, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5591663e0d0, moduleTitle=感染性眼病细菌学检查操作专家共识（2019）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5591663e0d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

眼病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#乳腺癌# #前列腺癌# #眼病# #基因编辑疗法#

‘四大顶刊’一周研究导读：基因编辑疗法治疗眼病，再获突破性进展；乳腺癌可少切除，还可降低水肿风险；尿液检测可准确诊断高级别前列腺癌，可减少约一半的不必要活检

2024-05-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#干眼# #眼病#

眼干、迎风流泪……你的眼睛可能生病了！JAMA子刊：这些方法或有效

2023-12-27发表于上海

pps20023 (审核中...)

前往app查看评论内容

#眼病#

甲亢治疗中最易被忽略的一环！《2021年欧洲Graves眼病临床实践管理指南》解读

2022-08-09

pps20023 (审核中...)

前往app查看评论内容

#眼病#

BMC Ophthalmol ：泪腺脱出程度与甲状腺相关眼病临床特征相关性的回顾性观察

2022-02-25

pps20023 (审核中...)

前往app查看评论内容

#眼病#

ProQR的RNA疗法在关键的遗传性眼病研究中失败

2022-02-16

pps20023 (审核中...)

前往app查看评论内容

#眼病#

Thyroid:短期口服或静脉使用激素预防放射性碘消融术Graves病患者眼病的进展

2021-09-25

pps20023 (审核中...)

前往app查看评论内容

#眼病#

Thyroid:Graves眼病患者使用前列腺素F2-α滴眼液（比马前列素）

2021-09-24

pps20023 (审核中...)

前往app查看评论内容

#眼病#

JCEM：1型糖尿病患者腰围身高比和严重糖尿病眼病风险之间的关系

2021-09-14

pps20023 (审核中...)

前往app查看评论内容

#眼病#

JCEM：利妥昔单抗在治疗Graves眼病患者中没有获益？

2021-09-07

pps20023 (审核中...)

前往app查看评论内容

#眼病#

JCEM：利妥昔单抗靶向治疗在活动性中度至重度Graves眼病患者的疗效

2021-09-05

pps20023 (审核中...)

前往app查看评论内容

#眼病#

FDA干眼病治疗药物开发指南（草案） 2020

2021-03-18

pps20023 (审核中...)

前往app查看评论内容

#眼病#

沉默的致盲性眼病—青光眼，离我们不远

2021-03-08

pps20023 (审核中...)

前往app查看评论内容

#眼病#

Nat Biomed Eng ：单碱基编辑首次在治疗遗传性眼病上取得成功，安全高效治疗先天性黑蒙症

2020-10-24

pps20023 (审核中...)

前往app查看评论内容

#眼病#

揉眼睛揉出了血斑？这些眼病看着吓人，多数不用治

2020-09-26

pps20023 (审核中...)

前往app查看评论内容

#眼病#

女，12岁，色素性青光眼病例

2020-07-01

pps20023 (审核中...)

前往app查看评论内容

#眼病#

HBM9161针对Graves眼病的临床试验获NMPA批件

2020-06-04

pps20023 (审核中...)

前往app查看评论内容

#眼病#

STEM CELL REP：烟酰胺可缓解纤维化眼病及视力丧失

2020-04-09

pps20023 (审核中...)

前往app查看评论内容

#眼病#

2019美国甲状腺学会ATA：临床试验证实Teprotumumab可显着改善甲状腺眼病的眼胀、复视和炎症

2019-11-06

pps20023 (审核中...)

前往app查看评论内容

#眼病#

“Graves眼病” 越治越重！主治医生该何去何从？

2019-10-11

pps20023 (审核中...)

前往app查看评论内容

#眼病#

感染性眼病细菌学检查操作专家共识（2019）

2019-05-20

科室
- - 订阅+
  - 更多科室
工具
服务